Literature DB >> 27665620

Cholera, 2015.

.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27665620

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  16 in total

1.  Utilization of Small RNA Genes to Distinguish Vibrio cholerae Biotypes via Multiplex Polymerase Chain Reaction.

Authors:  Siti Aminah Ahmed; Carsten A Raabe; Hong Leong Cheah; Chee Hock Hoe; Timofey S Rozhdestvensky; Thean Hock Tang
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

2.  Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia.

Authors:  Protim Sarker; Atanu Banik; Roger Stromberg; Gudmundur H Gudmundsson; Rubhana Raqib; Birgitta Agerberth
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

3.  Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor.

Authors:  Shamila Sarwar; Asif Ali; Mahadeb Pal; Pinak Chakrabarti
Journal:  J Biol Chem       Date:  2017-09-07       Impact factor: 5.157

Review 4.  Emerging and Reemerging Diseases in the World Health Organization (WHO) Eastern Mediterranean Region-Progress, Challenges, and WHO Initiatives.

Authors:  Evans Buliva; Mohamed Elhakim; Nhu Nguyen Tran Minh; Amgad Elkholy; Peter Mala; Abdinasir Abubakar; Sk Md Mamunur Rahman Malik
Journal:  Front Public Health       Date:  2017-10-19

5.  Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.

Authors:  Marc Poncin; Gideon Zulu; Caroline Voute; Eva Ferreras; Clara Mbwili Muleya; Kennedy Malama; Lorenzo Pezzoli; Jacob Mufunda; Hugues Robert; Florent Uzzeni; Francisco J Luquero; Elizabeth Chizema; Iza Ciglenecki
Journal:  Bull World Health Organ       Date:  2017-10-19       Impact factor: 9.408

6.  What We Are Watching-Top Global Infectious Disease Threats, 2013-2016: An Update from CDC's Global Disease Detection Operations Center.

Authors:  Kira A Christian; A Danielle Iuliano; Timothy M Uyeki; Eric D Mintz; Stuart T Nichol; Pierre Rollin; J Erin Staples; Ray R Arthur
Journal:  Health Secur       Date:  2017-08-14

Review 7.  Carbohydrate inhibitors of cholera toxin.

Authors:  Vajinder Kumar; W Bruce Turnbull
Journal:  Beilstein J Org Chem       Date:  2018-02-21       Impact factor: 2.883

8.  Crystal structure of an inactive variant of the quorum-sensing master regulator HapR from the protease-deficient non-O1, non-O139 Vibrio cholerae strain V2.

Authors:  Justin Cruite; Patrick Succo; Saumya Raychaudhuri; F Jon Kull
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-05-17       Impact factor: 1.056

9.  Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice.

Authors:  Kizuku Watanabe; Jiro Kato; Jianfeng Zhu; Hirotake Oda; Hiroko Ishiwata-Endo; Joel Moss
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

10.  South-South cooperation as a mechanism to strengthen public health services in Africa: experiences, challenges and a call for concerted action.

Authors:  Olushayo Olu; Amos Petu; Martin Ovberedjo; Diane Muhongerwa
Journal:  Pan Afr Med J       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.